80 related articles for article (PubMed ID: 35834270)
1. Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing.
Tuncer SB; Celik B; Erciyas SK; Erdogan OS; Gültaslar BK; Odemis DA; Avsar M; Sen F; Saip PM; Yazici H
Pathol Res Pract; 2024 Feb; 254():155075. PubMed ID: 38219492
[TBL] [Abstract][Full Text] [Related]
2. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Li H; Engel C; de la Hoya M; Peterlongo P; Yannoukakos D; Livraghi L; Radice P; Thomassen M; Hansen TVO; Gerdes AM; Nielsen HR; Caputo SM; Zambelli A; Borg A; Solano A; Thomas A; Parsons MT; Antoniou AC; Leslie G; Yang X; Chenevix-Trench G; Caldes T; Kwong A; Pedersen IS; Lautrup CK; John EM; Terry MB; Hopper JL; Southey MC; Andrulis IL; Tischkowitz M; Janavicius R; Boonen SE; Kroeldrup L; Varesco L; Hamann U; Vega A; Palmero EI; Garber J; Montagna M; Van Asperen CJ; Foretova L; Greene MH; Selkirk T; Moller P; Toland AE; Domchek SM; James PA; Thorne H; Eccles DM; Nielsen SM; Manoukian S; Pasini B; Caligo MA; Lazaro C; Kirk J; Wappenschmidt B; Spurdle AB; Couch FJ; Schmutzler R; Goldgar DE; ;
Genet Med; 2022 Jan; 24(1):119-129. PubMed ID: 34906479
[TBL] [Abstract][Full Text] [Related]
3. Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants.
Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
[TBL] [Abstract][Full Text] [Related]
4. Racial and ethnic disparities in mortality among breast cancer survivors after a second malignancy.
Deng Z; Jones MR; Wang MC; Wolff AC; Visvanathan K
J Natl Cancer Inst; 2023 Mar; 115(3):279-287. PubMed ID: 36529890
[TBL] [Abstract][Full Text] [Related]
5. Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.
Al Saati A; Vande Perre P; Plenecassagnes J; Gilhodes J; Monselet N; Cabarrou B; Lignon N; Filleron T; Telly D; Perello-Lestrade E; Feillel V; Staub A; Martinez M; Chipoulet E; Collet G; Thomas F; Gladieff L; Toulas C
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762649
[TBL] [Abstract][Full Text] [Related]
6. Endometrial Cancer Risk Among Germline
Sorouri K; Lynce F; Feltmate CM; Davis MR; Muto MG; Konstantinopoulos PA; Stover EH; Kurian AW; Hill SJ; Partridge AH; Tolaney SM; Garber JE; Bychkovsky BL
JCO Precis Oncol; 2023 Sep; 7():e2300290. PubMed ID: 38061009
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer.
Yadav S; LaDuca H; Polley EC; Hu C; Niguidula N; Shimelis H; Lilyquist J; Na J; Lee KY; Gutierrez S; Yussuf A; Hart SN; Davis BT; Chao EC; Pesaran T; Goldgar DE; Dolinsky JS; Couch FJ
J Natl Cancer Inst; 2021 Oct; 113(10):1429-1433. PubMed ID: 33146377
[TBL] [Abstract][Full Text] [Related]
8. Second Primary Breast Cancer in Young Breast Cancer Survivors.
Brantley KD; Rosenberg SM; Collins LC; Ruddy KJ; Tamimi RM; Schapira L; Borges VF; Warner E; Come SE; Zheng Y; Kirkner GJ; Snow C; Winer EP; Partridge AH
JAMA Oncol; 2024 Apr; ():. PubMed ID: 38602683
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis.
Hoxhaj I; Vukovic V; Boccia S; Pastorino R
BMC Cancer; 2021 Jun; 21(1):660. PubMed ID: 34078296
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic Germline Mutations in DNA Repair Genes in Combination With Cancer Treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer.
Qin N; Wang Z; Liu Q; Song N; Wilson CL; Ehrhardt MJ; Shelton K; Easton J; Mulder H; Kennetz D; Edmonson MN; Rusch MC; Downing JR; Hudson MM; Nichols KE; Zhang J; Robison LL; Yasui Y
J Clin Oncol; 2020 Aug; 38(24):2728-2740. PubMed ID: 32496904
[TBL] [Abstract][Full Text] [Related]
11. Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors.
Wagner MA; Koleck TA; Conway A; Bender CM; Conley YP
Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002974
[TBL] [Abstract][Full Text] [Related]
12. Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study.
Marcheselli R; Marcheselli L; Cortesi L; Bari A; Cirilli C; Pozzi S; Ferri P; Napolitano M; Federico M; Sacchi S
J Breast Cancer; 2015 Dec; 18(4):378-85. PubMed ID: 26770245
[TBL] [Abstract][Full Text] [Related]
13. Puzzling phenomenon: adult-onset cancer predisposition and pediatric cancer.
Kuhlen M; Hofmann TG; Golas MM
Trends Cancer; 2024 Mar; ():. PubMed ID: 38503638
[TBL] [Abstract][Full Text] [Related]
14. Risk of second primary cancer among breast cancer patients: A systematic review and meta-analysis.
Parhizgar P; Bahadori Monfared A; Mohseny M; Keramatinia A; Hashemi Nazari SS; Rahman SA; Al Marzouqi A; Al-Yateem N; Mosavi Jarrahi A
Front Oncol; 2022; 12():1094136. PubMed ID: 36733366
[TBL] [Abstract][Full Text] [Related]
15. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.
Ramin C; Veiga LHS; Vo JB; Curtis RE; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Breast Cancer Res; 2023 May; 25(1):50. PubMed ID: 37138341
[TBL] [Abstract][Full Text] [Related]
16. Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis.
Allen I; Hassan H; Sofianopoulou E; Eccles D; Turnbull C; Tischkowitz M; Pharoah P; Antoniou AC
Breast Cancer Res; 2023 Feb; 25(1):18. PubMed ID: 36765408
[TBL] [Abstract][Full Text] [Related]
17. Satisfaction and Well-Being After Contralateral Prophylactic Mastectomy Among BRCA Mutation Carriers and Noncarriers: A Longitudinal Analysis of BREAST-Q Domains.
Myers SP; Tadros AB; Sevilimedu V; Nelson JA; Le T; Garcia P; Morrow M; Lee MK
Ann Surg Oncol; 2023 Nov; 30(12):7116-7123. PubMed ID: 37581851
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of nomograms to predict the survival probability and occurrence of a second primary malignancy of male breast cancer patients: a population-based analysis.
Huang H; Li Z; Huang Z; Huang L; Liu W; Liu G; Mo Y
Front Oncol; 2023; 13():1076997. PubMed ID: 37152061
[TBL] [Abstract][Full Text] [Related]
19. Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study.
Chen F; Park SL; Wilkens LR; Wan P; Hart SN; Hu C; Yadav S; Couch FJ; Conti DV; de Smith AJ; Haiman CA
Cancer Res; 2022 Sep; 82(18):3201-3208. PubMed ID: 35834270
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
